Pharmacokinetics and pharmacodynamics of moist snuff in humans

INTERVENTION Four brands of moist snuff and a non-tobacco mint snuff were tested. Subjects reported to the laboratory for five experimental sessions. After baseline measurement of dependent variables, each subject placed 2 g of one of the brands of snuff (or one Skoal Bandits pouch) between the cheek and gum for 30 minutes. The subjects remained in the experimental laboratory for an additional 60 minutes. SUBJECTS Ten volunteers who were daily users of smokeless tobacco. MAIN OUTCOME MEASURES Plasma nicotine concentration, cardiovascular effects, and subjective effects. RESULTS Large amounts of nicotine were delivered rapidly to the bloodstream. The amount of nicotine absorbed and the rate of absorption were related to the pH of the snuff product in aqueous suspension. Cardiovascular and subjective effects were related to the amount of nicotine absorbed. CONCLUSIONS Snuff products are capable of rapidly delivering high doses of nicotine, which can lead to dependence. Long-term use of snuff can lead to a number of adverse health effects including oral cancers, cardiovascular diseases, and gingival diseases. For these reasons, it is important that the public health community considers oral snuff use as a burden on public health in the same way that cigarette smoking is recognised.

[1]  J. Henningfield,et al.  Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. , 1997, Tobacco control.

[2]  J. Henningfield,et al.  Smokeless Tobacco: an Addicting Drug , 1997, Advances in dental research.

[3]  M. Djordjevic,et al.  Chemical Composition and Carcinogenicity of Smokeless Tobacco , 1997, Advances in dental research.

[4]  D. Winn,et al.  Oral Mucosal Smokeless Tobacco Lesions among Adolescents in the United States , 1997, Journal of dental research.

[5]  G. Connolly,et al.  Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. , 1995, Journal of the National Cancer Institute.

[6]  D. Hatsukami,et al.  Measuring dependence in smokeless tobacco users. , 1995, Addictive behaviors.

[7]  G. Connolly.  The marketing of nicotine addiction by one oral snuff manufacturer , 1995 .

[8]  J. Henningfield,et al.  Estimation of available nicotine content of six smokeless tobacco products , 1995 .

[9]  J E Henningfield,et al.  Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. , 1990, JAMA.

[10]  N. Benowitz,et al.  Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum , 1988, Clinical pharmacology and therapeutics.

[11]  P. Jenner,et al.  A possible relation between pKa1 and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man , 1972, The Journal of pharmacy and pharmacology.

[12]  E. O. O. Smoking.  "The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General" (Title Page through Table of Contents) , 1988 .

[13]  E. O. O. Smoking.  "The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General" (Index) , 1988 .

[14]  S. Schinke,et al.  Preventing tobacco use among young people. , 1986, Health & social work.